This report breaks down how life sciences companies are evaluating locations today. It focuses on risk, infrastructure, and long-term viability—not just cost. Download the full report to explore: Why site selection is now a risk decision, not a cost comparison How talent concentration (nearly 6x the national average) impacts hiring and timelines What “research continuity” looks like and how it supports long-term innovation The role of GMP experience and regulatory fluency in scaling operations How infrastructure, water, and utilities affect advanced manufacturing readiness Why proximity to 40% of the U.S. market changes distribution strategy How cluster density reduces vendor friction and speeds execution What separates Middlesex County, NJ, from other major life sciences hubs
